Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-18-016321

Chief Scientific Officer bought 10,000 shares at $0.45 ($4,499)

From the SEC's structured data for this filing

Trades in this filing

Ludwig Dale L. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-19 Purchase : show line 1 in the form +10,000 $0.45 $4,499 10,000 D
Open-market purchases · 10,000 sh · avg $0.45 · $4,499
Loading xslF345X03/ownership.xml…